Artificial membrane binding proteins to direct stem cells to the myocardium

Artificial membrane binding proteins to direct stem cells to the myocardium
Fig. 1 The artificial plasma membrane binding construct. (a) Schematic showing the interaction of the polymer surfactant conjugated supercharged fusion [CshA_scGFP][S] construct with the bilayer of the cytoplasmic membrane. The structure shows the surface charge potential, highlighting the high positive charge (blue) on the supercharged GFP domain and the negative charge (red) on the CshA globular domain, as well as the “catch” and “clamp” domains of CshA. (b) The structure of the anionic polymer surfactant glycolic acid ethoxylate 4-nonylphenyl ether (S), which electrostatically complexes with the supercharged GFP moiety. Credit: Chemical Science, open access: https://pubs.rsc.org/en/content/articlelanding/2019/sc/c9sc02650a#!divAbstract

In a world first, scientists have found a new way to direct stem cells to heart tissue. The findings, led by researchers at the University of Bristol and published in Chemical Science, could radically improve the treatment for cardiovascular disease, which causes more than a quarter of all deaths in the UK.

To date, trials using , which are taken and grown from the patient or donor and injected into the patient's heart to regenerate damaged tissue, have produced promising results.

However, while these next generation cell therapies are on the horizon, significant challenges associated with the distribution of the stem cells have remained. High blood flow in the heart combined with various 'tissue sinks," that circulating cells come into contact with, means the majority of the stem cells end up in the lungs and spleen.

Now, researchers from Bristol's School of Cellular and Molecular Medicine have found a way to overcome this by modifying stem cells with a special protein so they 'home' to heart tissue.

Dr. Adam Perriman, the study's lead author, associate professor in Biomaterials, UKRI Future Leaders Fellow and founder of the cell therapy technology company CytoSeek, explained: "With regenerative cell therapies, where you are trying to treat someone after a heart attack, the cells rarely go to where you want them to go. Our aim is to use this technology to re-engineer the membrane of cells, so that when they're injected, they'll home to specific tissues of our choice.

World first: Homing instinct applied to stem cells show cells 'home' to cardiac tissue
Human mesenchymal stems exhibit green fluorescence after being 'painted' by the designer protein. Credit: University of Bristol

"We know that some contain properties that enable them to detect and 'home' to diseased tissue. For example, the oral bacterial found in our mouths can occasionally cause strep throat. If it enters the blood stream it can 'home' to damaged tissue in the heart causing infective endocarditis. Our aim was to replicate the homing ability of bacteria cells and apply it to stem cells."

The team developed the technology by looking at how bacterial cells use a protein called an adhesin to 'home' to . Using this theory, the researchers were able to produce an artificial cell membrane binding version of the adhesin that could be 'painted' on the outside of the stem cells. In an , the team were able to demonstrate that this new cell modification technique worked by directing stem cells to the heart in a mouse.

World first: Homing instinct applied to stem cells show cells 'home' to cardiac tissue
Schematic showing the interaction of the designer protein on the surface of the stem cell with heart fibronectin. Credit: University of Bristol

Dr. Perriman added: "Our findings demonstrate that the cardiac homing properties of infectious bacteria can be transferred to human stem cells. Significantly, we show in a that the designer adhesin protein spontaneously inserts into the plasma membrane of the stem cells with no cytotoxity, and then directs the modified cells to the heart after transplant. To our knowledge, this is the first time that the targeting properties of infectious bacteria have been transferred to mammalian .

"This new technique carries enormous potential for the seven million people currently living with disease in the UK."


Explore further

Welding with stem cells for next-generation surgical glues

More information: Wenjin Xiao et al. Designer artificial membrane binding proteins to direct stem cells to the myocardium, Chemical Science (2019). DOI: 10.1039/C9SC02650A
Journal information: Chemical Science

Citation: Artificial membrane binding proteins to direct stem cells to the myocardium (2019, July 3) retrieved 21 October 2019 from https://phys.org/news/2019-07-artificial-membrane-proteins-stem-cells.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Jul 03, 2019
I don't understand much of this but could the same technique (with more research) be used to target other tissues? For example the cartridge in arthritic patients?

Jul 03, 2019
Did you mean "joint capsule?"

Assuming that's what you meant, probably yes but there's no guarantee that it would fix arthritic joint capsules.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more